
|Articles|May 1, 2005
- Volume 0 0
On-line Drug Consumers Willing to Take Risk
Advertisement
Despite lack of FDA approval, more than a third of on-line consumers said that they would purchase prescription medications. The survey, conducted by comScore Networks, found that 54% of the participants were "very concerned" about the safety of on-line drugs, compared with 30% of the respondents who were not concerned. Of the 315 respondents, 38% reported that they would purchase drugs online "that are not FDA-approved but work for me," compared with 45% who said that they would not.
Articles in this issue
over 21 years ago
Top 200 Prescription Drugs of 2004over 21 years ago
New Drugs of 2004over 21 years ago
COMPOUNDING HOTLINEover 21 years ago
Avastin Decreases Lung Cancer Patients' Mortalityover 21 years ago
Simvastatin Improves Mortality of Heart Failure Patientsover 21 years ago
Pharma Companies Developing Antismoking Drugsover 21 years ago
Handbook Disclaimers Permit Dismissal of Pharmacistover 21 years ago
Annual Eye Exams Unnecessary for Someover 21 years ago
Safe Options for Needle Disposalover 21 years ago
Prevention Can Save $2.5 Billion AnnuallyAdvertisement
Related to this article

Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.

Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.

A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.

Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.

Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.

Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.

Peer Reviewed
Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Dapagliflozin in Heart Failure: Congestion Isn't the Gatekeeper
2
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
3
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
4
Ambulatory Pharmacists Convene in Boston at NEIAP's 2026 Annual Forum
5

